Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) provides the following updates.

The Company has reviewed the CBD edibles opportunity and has strategically adapted our strategy for this emerging market. Naturally Splendid, will continue to focus our core strengths manufacturing nutritious food, with plant-based ingredients in our SQF2 Certified food manufacturing facility while the market for edibles continues to evolve. We will leverage this expertise to extend into the ‘edibles market’ as opportunities warrant and the necessary licensing secured.


In 2019 many companies involved in the cannabis industry began to tighten their budgets and and/or reduced the scope of projects given the state of the cannabis market in Canada. That trend is continuing into 2020. It is prudent for Naturally Splendid to adjust strategies to best suit these challenging times for the cannabis industry.

Therefore, after a thorough review, the agreements with AlternaMedz Canada Holdings Inc. and Prairie Pure (1159705 BC Ltd.) have been terminated.

AlternaMedz Agreement Terminated

The AlternaMedz agreement for the purchase of a late stage Processor License and buildout of a cannabidiol (CBD) extraction facility in Innisfil, Ontario has been terminated. The Termination is due to the fact that Naturally Splendid and AlternaMedz failed to satisfy the closing conditions by July 31, 2019. With the termination of this agreement, the Company will focus capital spends on increasing capacity and efficiencies within our core business manufacturing nutritious bars and bites.

Prairie Pure Agreement Terminated

The Prairie Pure agreement was based on Naturally Splendid providing equipment for the extraction of cannabidiol (CBD) from hemp at a facility in the state of Oregon, USA. This agreement has been terminated as Prairie Pure was not able to secure the necessary equipment and liability insurance for this operation to the satisfaction of Naturally Splendid. The Company is reviewing several opportunities to put the extraction units into use in other business arrangements.

Naturally Splendid CEO Mr. J. Craig Goodwin states, “There has been significant cannabinoid extraction operations and capacity brought online over the last 12 months or so. In our opinion there is sufficient cannabidiol (CBD) extraction capacity, to satisfy current consumer demand. However, we believe there is under capacity manufacturing infused food products. It is with this in mind that the Company will focus on leveraging our food making expertise, as we revise our ‘edibles strategy’, to focus on the production of CBD-infused food, rather than the actual extraction process.

The Company’s extraction and edibles strategy has come full circle and we will focus our attention on securing a Processor License in Pitt Meadows BC, for the purpose of manufacturing infused edibles. This makes the most sense economically and geographically allowing us to best utilize the food manufacturing expertise that is already available within our SQF2 facility”.

Prior to cannabis regulations changing in 2018, the Company engaged Cannabis Compliance Inc. to prepare a site plan for their Pitt Meadows location for the purpose of extracting cannabinoids and processing into edibles. We are amending that application to reflect current regulations regarding the processing of cannabinoids into food products and submitting for review and eventual approval.

In December 2019, Prohibition Partners reported that, “For 2020: We will see more and more industries across the board incorporating cannabidiol into their product ranges. This is likely to spill over into a greater array of food products, and food operators with clean eating and veganism are likely to be key conduits. Sports performance (including sports drinks) and recovery/injury products will also be a major category in development that will also pay greater attention to CBD; however, we may also see the entire sports drinks category shift its focus in favor of mental stimulation and nootropics (including CBD) rather than on simple physical exertion, as the drain on mental time and energy continues to be much higher than the physical demands of modern living. Household goods will also pick up on the trend, with CBD-based sleep aids an exciting new avenue for a whole host of product development”.

Naturally Splendid Vice President Mr. Bryan Carson states, “We field multiple inquiries regarding edibles from our existing clients as well as from new contacts looking for a manufacturer. The expertise we have developed at Prosnack will be transferable to the buildout of a facility dedicated to edibles. We look forward to expanding our services to include CBD edibles in due time and with the proper licensing in place. In the meantime, we will focus on servicing our growing roster of contract manufacturing clients”.

About Naturally Splendid Enterprises Ltd.

NSE has established numerous healthy, functional foods under recognized brands such as Natera Sport(TM), Natera Hemp Foods, CHII (TM), Elevate Me(TM) and Woods Wild Bar. The Company has a myriad of new products and line extensions under development that are approaching launch. NSE has also developed proprietary technologies for the extraction of high demand, healthy omega 3 and 6 oils from hemp. (NSE sales revenues for the first half 2019 exceeded FY2018).NSE is the current “go-to” manufacturer for healthy, functional food products and ingredients focusing on plant-based ingredients. The Company provides contract manufacturing services for many global healthy food companies, private labelling a wide variety of nutritional food products destined for global healthy food markets. NSE plans to utilize current and new technologies to meet the expected exponential demand developing in the cannabis market. Pending appropriate NSE licensing and regulations in permitting jurisdictions, NSE’s current production facilities will be one of very few facilities that is capable of meeting the demand for infused edibles and oils for both in-house and contract manufacturers’ brands.

For more information e-mail info@naturallysplendid.com or call Investor Relations at 604-673-9573

On Behalf of the Board of Directors

Mr. J. Craig Goodwin

CEO, President, Director

Contact Information

Naturally Splendid Enterprises Ltd.

(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)

#108-19100 Airport Way

Pitt Meadows, BC, V3Y 0E2

Office: (604) 465-0548

Fax: (604) 465-1128

E-mail: info@naturallysplendid.com

Website: www.naturallysplendid.com

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; customers will complete on sales contracts; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Click here to connect with Naturally Splendid (TSXV:NSP) for an Investor Presentation.

 

Source

  Life Science and Healthcare Investing in 2020 report cover

Life Science and Healthcare Investing in 2020

 
The life science and healthcare market is a booming, multi-billion dollar industry. Read our 2020 life science outlook report!
 

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less